Hydroxychloroquine vs. Methotrexate for Lichen Planopilaris
Treatments studied
Part of Skin clinical trials.
This trial compares two medications, hydroxychloroquine and methotrexate, to see which works better for treating lichen planopilaris (a scalp condition that causes hair loss). Patients can choose their treatment or be assigned based on their health needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with lichen planopilaris (LPP) by a doctor.
- You are willing to take either hydroxychloroquine or methotrexate and follow the study schedule.
- You don't have any allergies or medical reasons that prevent you from taking these medications.
- If you can't take one medication, you can still join and take the other one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two common medicines, hydroxychloroquine and methotrexate, to see which works better for treating frontal fibrosing alopecia (a type of hair loss). You and your doctor can choose which treatment you prefer.
This trial tests a new medication called brepocitinib to treat lichen planopilaris (LPP), a condition that causes scarring and hair loss on the scalp. The study aims to see if this drug can reduce symptoms and help hair regrow.
This study compares two medicines, cyclosporine and methotrexate, to see which works better for children with alopecia areata (a condition causing hair loss). It aims to help doctors choose the best treatment for each child.
This study compares two systemic medicines, methotrexate and acitretin, to see which works better for people with generalized lichen planus (a skin condition affecting large areas of the body). It may help find a more effective treatment option.
This study tests a new medication called nemolizumab for people with lichen planopilaris (LPP), a type of scarring hair loss. It aims to see if the drug can help reduce scalp itching and improve the condition.
This study tests the drug methotrexate as a treatment for severe vulvar lichen sclerosus that has not responded to strong steroid creams. It aims to see if methotrexate can reduce symptoms and prevent further scarring.
Hear when a new Lichen Planopilaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.